as 07-04-2025 11:32am EST
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
Founded: | 1998 | Country: | United States |
Employees: | N/A | City: | REDWOOD CITY |
Market Cap: | 7.5B | IPO Year: | N/A |
Target Price: | $142.00 | AVG Volume (30 days): | 1.6M |
Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 1.14 | EPS Growth: | 8.36 |
52 Week Low/High: | $29.42 - $117.33 | Next Earning Date: | 07-28-2025 |
Revenue: | $685,446,000 | Revenue Growth: | 30.93% |
Revenue Growth (this year): | 35.83% | Revenue Growth (next year): | 35.24% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Robb Gary Charles | CORT | Chief Business Officer | Jun 16 '25 | Sell | $70.77 | 3,185 | $225,402.45 | 13,364 | |
Swisher Daniel N JR | CORT | Director | Jun 10 '25 | Sell | $70.61 | 2,200 | $155,342.00 | 0 | |
Guyer William | CORT | Chief Development Officer | Jun 10 '25 | Sell | $72.56 | 20,000 | $1,448,474.57 | 5,487 | |
Lyon Joseph Douglas | CORT | See Remarks | Jun 2 '25 | Sell | $78.31 | 5,000 | $390,218.44 | 9,751 | |
Maduck Sean | CORT | See Remarks | Jun 2 '25 | Sell | $79.36 | 20,000 | $1,581,686.49 | 31,953 | |
BELANOFF JOSEPH K | CORT | Chief Executive Officer | Jun 2 '25 | Sell | $81.86 | 40,000 | $3,314,309.74 | 2,901,985 | |
Robb Gary Charles | CORT | Chief Business Officer | May 20 '25 | Sell | $75.85 | 2,279 | $172,862.15 | 13,364 | |
MAHONEY DAVID L | CORT | Director | May 16 '25 | Sell | $74.41 | 27,352 | $2,030,452.49 | 0 | |
Guyer William | CORT | Chief Development Officer | May 16 '25 | Sell | $74.17 | 32,262 | $2,393,014.49 | 5,487 | |
Swisher Daniel N JR | CORT | Director | May 12 '25 | Sell | $71.86 | 2,200 | $158,526.00 | 0 |
CORT Breaking Stock News: Dive into CORT Ticker-Specific Updates for Smart Investing
Zacks
9 days ago
StockStory
10 days ago
Argus Research
12 days ago
Insider Monkey
12 days ago
Business Wire
13 days ago
Simply Wall St.
14 days ago
Simply Wall St.
14 days ago
Argus Research
a month ago
The information presented on this page, "CORT Corcept Therapeutics Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.